WRLD A.LIVE

03:001 report

• Biomarker Tests and Gaps in Legal Protection Penn LDI

02:002 reports

• Large global study examines Alzheimer’s blood biomarker across racial and ethnic groups Keck School of Medicine of USC
• Alzheimer's blood biomarker tracks brain amyloid similarly across racial groups, study finds Medical Xpress

18:004 reports

• Routine blood test may suggest future dementia risk Medical Xpress
• New Alzheimer’s treatments, testing offer hope for slowing cognitive decline Boston 25 News
• Promising advancements in Alzheimer's disease management Antigo Times
• Early Alzheimer’s Biomarker Test Results Boost Diagnostic Certainty, Guide Clinical Care Medscape

17:00nothing heard

16:001 report

• A protein is one of the culprits behind dementia. Scientists found a way to stop it ThePrint

15:00nothing heard

14:00nothing heard

13:00nothing heard

12:00nothing heard

11:002 reports

• A region in tau protein that promotes fibril growth identified — News-Medical UA.NEWS
• Scientists pinpoint key hotspot driving tau propagation in dementia News-Medical

10:00nothing heard

09:00nothing heard

08:00nothing heard

07:002 reports

• Serine-65 phosphorylated ubiquitin associates with soluble tau and seeding activity in Alzheimer’s disease Nature
• %p-Tau217 by Race and Ethnicity in Preclinical AD JAMA

06:00nothing heard

05:002 reports

• Water’s Hidden Shape Reveals the Trigger Point That Spreads Dementia Proteins Bioengineer.org
• Shape-Shifting Tau Filaments Could Lead to New Dementia Therapies The Scientist

04:00nothing heard

03:001 report

• The shape of water at a key tau hotspot helps drive dementia-linked clumping Medical Xpress

20:001 report

• Haemoglobin count may suggest future dementia risk healthcare-in-europe.com

19:00nothing heard

18:00nothing heard

17:00nothing heard

16:00nothing heard

15:00nothing heard

14:001 report

• DNA changes in Alzheimer’s disease: Expert explains what they mean to patients, families EurekAlert!

13:00nothing heard

12:00nothing heard

11:00nothing heard

10:00nothing heard

09:004 reports

• In people with Down syndrome, β-synuclein rose earlier than other Alzheimer’s markers — News-Medical UA.NEWS
• Alzheimer’s-Related Blood Signal Emerges Decades Before Symptoms in Down Syndrome Technology Networks
• Down syndrome and Alzheimer’s connection Chicago Health Magazine
• A study links a blood protein to memory and brain changes in Down syndrome News-Medical

11:003 reports

• Can Blood-Based Molecules Provide a Window Into Brain Disease? Psychiatric Times
• A rare healthcare issue both parties agree on The Washington Post
• Routine blood test may offer clues to future dementia risk News-Medical

21:002 reports

• Estimating cognitive impairment risk, timing National Institutes of Health (NIH) | (.gov)
• Evaluating Blood Biomarkers for Alzheimer’s Disease Staging The Scientist

20:00nothing heard

19:00nothing heard

18:00nothing heard

17:00nothing heard

16:00nothing heard

15:00nothing heard

14:00nothing heard

13:00nothing heard

12:00nothing heard

11:00nothing heard

10:00nothing heard

09:00nothing heard

08:00nothing heard

07:00nothing heard

06:00nothing heard

05:001 report

• Blood marker may flag Alzheimer's-related changes in Down syndrome decades before symptoms appear Medical Xpress

04:001 report

• Blood-Based Biomarkers for Alzheimer Disease: Accuracy, Limits, and Confounders Psychiatric Times

03:00nothing heard

02:001 report

• Blood-Based Biomarkers for Alzheimer Disease: Accuracy, Limits, and Confounders Psychiatric Times

01:005 reports

• Letter: Urge North Dakota's delegation to support the ASAP Act InForum
• Opinion - Kimberly Poore Moser: Kentucky families deserve to benefit from next era of Alzheimer’s detection NKyTribune
• BE WELL: Want to lower your risk of dementia? It doesn't involve a blood test GreenevilleSun.com
• Two very different Alzheimer’s tests just teamed up Longevity.Technology
• Could RNA in Blood Nanoparticles Enable Earlier Diagnosis of Alzheimer Disease? Psychiatric Times

22:002 reports

• Study finds β-synuclein as early blood-based biomarker of Alzheimer's in Down syndrome patients News-Medical
• For years, dementia researchers had no answers, but now the word ‘breakthrough’ is on their lips The Age